PVP Ventures Acquires 56% in Optimus Oncology for ₹55 Cr to Expand in Healthcare
K N Mishra
23/Apr/2025

What's covered under the Article:
-
PVP Ventures will invest ₹55 crore for a 56% stake in Optimus Oncology to grow its healthcare platform.
-
Optimus Oncology, founded by Tata Memorial-trained oncologists, currently runs radiation therapy centres in Maharashtra.
-
Board also approves the appointment of Mr. B. Vignesh Ram as Company Secretary & Compliance Officer w.e.f April 23, 2025.
PVP Ventures Limited has announced a significant decision at its Board meeting held on April 23, 2025, regarding the acquisition of a 56% stake in Optimus Oncology Private Limited. The company has approved an investment of approximately INR 55 crore for this strategic acquisition, which will involve a combination of primary growth capital infusion and buying out existing third-party institutional and individual shareholders.
Optimus Oncology, a company founded by Radiation Oncologists trained at the prestigious Tata Memorial Hospital, Mumbai, commenced its operations in 2018. The company primarily focuses on oncology care, especially radiation therapy, and operates Radiation Therapy Centres in Maharashtra. The acquisition aligns with PVP Ventures’ goal of expanding its presence in the healthcare sector, specifically in oncology care. This acquisition will enable PVP Ventures to further build a technology-centric healthcare platform.
In the same meeting, the Board of Directors also approved the Share Purchase, Share Subscription, and Shareholders Agreement (SPA) between PVP Ventures and Optimus Oncology Private Limited, outlining the terms and conditions of the deal. The acquisition is expected to be completed within the next 90 days, with no regulatory approvals required for the transaction.
Mr. B. Vignesh Ram was also appointed as the Company Secretary & Compliance Officer of PVP Ventures Limited, effective April 23, 2025. Mr. Ram is an associate member of the Institute of Company Secretaries of India (ICSI) and brings with him over 12 years of experience in corporate secretarial, legal, and regulatory compliance across various industries, including corporate consultancy, renewable energy, aquaculture, and real estate.
Transaction Details:
-
Total Consideration: INR 55 crore
-
Percentage of Shareholding Acquired: 56.01% post-acquisition
-
Focus of the Acquired Entity: Radiation therapy and oncology care with operations in Maharashtra.
-
Cost of Acquisition: INR 54.73 crore
-
Completion Timeline: Expected to complete within 90 days.
This acquisition represents an important step for PVP Ventures in its continued diversification into the healthcare sector, particularly with an emphasis on advanced cancer care and radiation therapy.
As part of its ongoing corporate governance initiatives, PVP Ventures has also made the appointment of a new Company Secretary & Compliance Officer official. This move is aimed at strengthening the company's corporate compliance framework and internal controls in light of its growing portfolio.
Key Takeaways:
-
PVP Ventures is set to acquire 56% of Optimus Oncology, an oncology-focused healthcare company.
-
The company will invest INR 55 crore in the acquisition, enhancing its healthcare portfolio.
-
Mr. B. Vignesh Ram has been appointed as the new Company Secretary & Compliance Officer.
With this acquisition, PVP Ventures aims to reinforce its position in the healthcare sector, especially in oncology, while further expanding its technology-driven healthcare services. The company’s proactive strategy in securing investments in high-growth sectors such as healthcare is designed to bolster its long-term growth prospects.
The Upcoming IPOs in this week and coming weeks are Ather Energy.
The Current active IPO are Tankup Engineers.
Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.
Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.
Related News
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.
Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.
We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.
By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.